Page 2 - Arnab Basu News Today

Kromek receives $1.6m in advanced imaging orders Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has secured four orders totalling $1.63m in the advanced imaging segment. The orders,...

Russian attacks on nuclear power stations have made the risks even greater

Arnab Basu joins other technology bosses ‘frustrated’ with London’s small-cap market after Kromek’s share price dropped more than 90 per cent since 2013

The MoU signed with West Bengal government to provide entrepreneurs 100 Million Learners Course free of cost also found mention at the event

Arnab Basu, MD, MPH, FACP, discusses molecular residual disease-guided adjuvant therapy in patients with renal cell carcinoma, highlighting the rationale and goals of the MRD gate RCC clinical trial.

Kromek Group PLC (AIM:KMK) said it has entered into a partnership with a blue-chip technology group to develop cadmium zinc telluride (CZT) based detectors...

Collaboration agreement with new CT technology partnerKromek and global technology solutions provider to develop next-generation CT detector technology Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, annou...

The following is a round-up of trading updates by London-listed companies, issued on Tuesday, and not separately reported by Alliance News: ---------- CloudCoCo Group PLC - London-based IT and...

By Anthony O. Goriainoff Kromek Group said it has received three orders worth more than $1 million in the chemical, biological, radiological and nuclear, or...

Kromek Group PLC (AIM:KMK) shares marched 24% higher to 5.15p after it reported winning a US$5.9 million contract from the US Department of Homeland...